₹1,480.00 33.00 (2.28%)
04:01 PM, 19-Dec-2024₹1,476.80 31.05 (2.15%)
03:49 PM, 19-Dec-2024BSE : 524816
NSE : NATCOPHARM
Sector : Health care
ISIN Code : INE987B01026
Last Updated: 19-Dec-2024 | 04:01 PM IST
Market Cap (₹ Cr) | 26,507 |
Traded Value (₹ Cr) | 20.72 |
Volume (Shares) | 1,40,031 |
Face Value (₹) | 2 |
52-Week High (₹) | 1,638.35 |
52-Week High Date | 12-Sep-2024 |
52-Week Low (₹) | 755.90 |
52-Week Low Date | 21-Dec-2023 |
All Time High (₹) | 1,638.35 |
All Time High Date | 12-Sep-2024 |
All Time Low (₹) | 1.60 |
All Time Low Date | 17-Sep-2001 |
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 26,449 |
EPS - TTM (₹) [C] | 108.58 |
P/E Ratio (X) [C] | 13.60 |
Face Value (₹) | 2 |
Latest Dividend (%) | 75.00 |
Latest Dividend Date | 27-Nov-2024 |
Dividend Yield (%) | 0.66 |
Book Value Share (₹) [C] | 399.19 |
P/B Ratio (₹) [C] | 3.70 |
Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
---|---|---|---|
Tata Equity P/E Fund - (G) | 223.38 | 16,23,982 | 2.59 |
Tata Equity P/E Fund-(IDCW-Trigger-Opt B-10%) | 223.38 | 16,23,982 | 2.59 |
Tata Equity P/E Fund - (IDCW-Trigger - Opt A - 5%) | 223.38 | 16,23,982 | 2.59 |
Tata Equity P/E Fund - Direct (G) | 223.38 | 16,23,982 | 2.59 |
Tata Equity P/E Fund - Dir(IDCW-Trigger-Opt A-5%) | 223.38 | 16,23,982 | 2.59 |
Tata Equity P/E Fund - Dir(IDCW-Trigger-Opt B-10%) | 223.38 | 16,23,982 | 2.59 |
Tata Small Cap Fund - Regular (G) | 96.29 | 7,00,000 | 1.01 |
Tata Small Cap Fund - Regular (IDCW) | 96.29 | 7,00,000 | 1.01 |
Tata Small Cap Fund - Direct (G) | 96.29 | 7,00,000 | 1.01 |
Tata Small Cap Fund - Direct (IDCW) | 96.29 | 7,00,000 | 1.01 |
Load more
Date | Broker | Action | Prices(₹) | Report |
---|---|---|---|---|
04-Oct-2024 | Edelweiss Securities | Hold | 1,440 | |
16-Feb-2023 | ICICI Direct | Hold | 565 |
Today's Low/High (₹) | 1,425.15 1,490.00 |
Week Low/High (₹) | 1,415.25 1,490.00 |
Month Low/High (₹) | 1,332.10 1,505.00 |
Year Low/High (₹) | 755.00 1,639.00 |
All time Low/High (₹) | 1.60 1,639.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | 0.45% | 0.43% | -2.55 | -2.43% |
1 Month | 8.10% | 8.22% | 2.11 | 1.84% |
3 Month | -2.53% | -2.52% | -4.77 | -5.76% |
6 Month | 26.01% | 25.96% | 2.43 | 1.85% |
1 Year | 89.65% | 89.64% | 10.89 | 11.65% |
3 Year | 75.24% | 75.02% | 38.95 | 41.02% |
Chairman & Managing Director : V C Nannapaneni
Vice Chairman & CEO : Rajeev Nannapaneni
Vice President & Director : PSRK Prasad
President & Director : D Linga Rao
Vice President & Director : Pavan Bhat
Company Sec. & Compli. Officer : Venkat Ramesh
Independent Director : A D Murthy Chavali
Independent Director : B. Lakshminarayana
Independent Director : Kantipudi Suma
Independent Director : Nitin Jain
Independent Director : Vijayabhaskar Dronadula
Registered Office: Natco House, Road No 2 Banjara Hills,Hyderabad,Telangana-500033 Ph: 91-040-23547532
1. What's the Natco Pharma Ltd share price today?
Natco Pharma Ltd share price was Rs 1,480.00 at 04:01 PM IST on 19th Dec 2024. Natco Pharma Ltd share price was up by 2.28% over the previous closing price of Rs 1,447.00. Natco Pharma Ltd share price trend:
2. How can I quickly analyse the performance of the Natco Pharma Ltd stock?
The performance of the Natco Pharma Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Natco Pharma Ltd?
Natco Pharma Ltd has a market capitalisation of Rs 26,507 crore.
4. What is Natco Pharma Ltd's 52-week high/low share price?
The Natco Pharma Ltd’s 52-week high share price is Rs 1,638.35 and 52-week low share price is Rs 755.90.
5. Is the Natco Pharma Ltd profitable?
On a consolidated basis, Natco Pharma Ltd reported a profit of Rs 661.10 crore on a total income of Rs 1,344.00 crore for the quarter ended 2024. For the year ended Sep 2024, Natco Pharma Ltd had posted a profit of Rs 676.50 crore on a total income of Rs 1,434.90 crore.
6. Which are Natco Pharma Ltd’s peers in the Health care sector?
Natco Pharma Ltd’s top 5 peers in the Health care sector are Laurus Labs, J B Chemicals &, Gland Pharma, Natco Pharma, Emcure Pharma, Wockhardt, Pfizer.
7. Who owns how much in Natco Pharma Ltd?
Key changes to the Natco Pharma Ltd shareholding are as follows: